Estimated Half-Life of SARS-CoV-2 Anti-Spike Antibodies More Than Double the Half-Life of Anti-nucleocapsid Antibodies in Healthcare Workers

Clin Infect Dis. 2021 Dec 16;73(12):2366-2368. doi: 10.1093/cid/ciab219.

Authors

Jan Van Elslande¹, Lien Gruwier¹, Lode Godderis^{2

3}, Pieter Vermeersch^{1

4}

Affiliations

¹ Clinical Department of Laboratory Medicine and National Reference Center for Respiratory Pathogens, University Hospitals Leuven, Leuven, Belgium.
² Environment and Health, Department of Public Health and Primary Care, KU Leuven , Leuven, Belgium.
³ IDEWE, External Service for Prevention and Protection at Work, Heverlee, Belgium.
⁴ KU Leuven, Department of Cardiovascular Sciences, Leuven, Belgium.

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Viral
COVID-19*
Half-Life
Health Personnel
Humans
SARS-CoV-2*

Substances

Antibodies, Viral